These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pleuropulmonary changes during treatment of Parkinson's disease with a long-acting ergot derivative, cabergoline. Frans E; Dom R; Demedts M Eur Respir J; 1992 Feb; 5(2):263-5. PubMed ID: 1348483 [TBL] [Abstract][Full Text] [Related]
6. [Pleural effusion induced by bromocriptine]. Diot E; Diot P; Le Rolland A; Jonville AP; Lasfargues G; Lemarie E; Lavandier M; Guilmot JL Rev Mal Respir; 1990; 7(2):175-7. PubMed ID: 2320790 [TBL] [Abstract][Full Text] [Related]
7. [Pleural effusion and constrictive pericarditis secondary to bromocriptine treatment]. Saura J; Aguilar M; Alió J Neurologia; 1991 Nov; 6(9):331-3. PubMed ID: 1809340 [TBL] [Abstract][Full Text] [Related]
8. Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos. Hillerdal G; Lee J; Blomkvist A; Rask-Andersen A; Uddenfeldt M; Koyi H; Rasmussen E Eur Respir J; 1997 Dec; 10(12):2711-5. PubMed ID: 9493648 [TBL] [Abstract][Full Text] [Related]
9. Pleuropulmonary reactions in patients on bromocriptine treatment. Tornling G; Unge G; Axelsson G; Noring L; Granerus AK Eur J Respir Dis; 1986 Jan; 68(1):35-8. PubMed ID: 3948932 [TBL] [Abstract][Full Text] [Related]
10. Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease. Todman DH; Oliver WA; Edwards RL Clin Exp Neurol; 1990; 27():79-82. PubMed ID: 2129961 [TBL] [Abstract][Full Text] [Related]
11. [Bromocriptine and pulmonary responses]. Kinnunen E; Viljanen A Duodecim; 1989; 105(19):1614-7. PubMed ID: 2806146 [No Abstract] [Full Text] [Related]
12. [Pleural effusion and severe edema of the lower limbs induced by bromocriptine]. Messiaen T; Lefebvre C; Weynand B; Pieters T Rev Med Interne; 1996; 17(8):680-3. PubMed ID: 8881198 [TBL] [Abstract][Full Text] [Related]
13. [Bromocriptine in Parkinson's disease: pleuropulmonary toxicity]. Douvier JJ; Vergeret J; Taytard A; Brottier E; Domblides P; Dubos F; Freour P Ann Med Interne (Paris); 1985; 136(5):416-8. PubMed ID: 4062141 [TBL] [Abstract][Full Text] [Related]
14. Pleuropulmonary disease as a side-effect of treatment with bromocriptine. Comet R; Domingo C; Such JJ; Ribera G; Sans J; Marín A Respir Med; 1998 Sep; 92(9):1172-4. PubMed ID: 9926176 [No Abstract] [Full Text] [Related]
15. Suggestive evidence for bromocriptine-induced pleurisy. Klaassen RJ; Troost RJ; Verhoeven GT; Krepel HP; van der Lely AJ Neth J Med; 1996 Jun; 48(6):232-6. PubMed ID: 8710045 [TBL] [Abstract][Full Text] [Related]
16. [Pleuro-pulmonary changes after bromocriptine treatment of parkinsonism]. Bøttcher J; Grøn U Ugeskr Laeger; 1981 Oct; 143(41):2648-9. PubMed ID: 7303288 [No Abstract] [Full Text] [Related]
17. [Diffuse interstitial lung disease without pleural involvement and high-dose bromocriptine]. Marsaudon E; Castet D; Barrault MF; Allais C Rev Mal Respir; 1997 Nov; 14(5):405-7. PubMed ID: 9480488 [TBL] [Abstract][Full Text] [Related]
18. [Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case]. Debove P; Simon F; Vaylet F; Renard JL; L'Her P Ann Med Interne (Paris); 1998 Apr; 149(3):167-71. PubMed ID: 11490541 [TBL] [Abstract][Full Text] [Related]
19. [Pleuropulmonary fibrosis and bromocriptine]. Vergeret J; Barat M; Taytard A; Bellvert P; Domblides P; Douvier JJ; Fréour P Sem Hop; 1984 Mar; 60(11):741-4. PubMed ID: 6324351 [TBL] [Abstract][Full Text] [Related]
20. Retroperitoneal fibrosis, skin and pleuropulmonary changes associated with bromocriptine therapy. Hely MA; Morris JG; Lawrence S; Jeremy R; Genge S Aust N Z J Med; 1991 Feb; 21(1):82-4. PubMed ID: 2036087 [No Abstract] [Full Text] [Related] [Next] [New Search]